RAMM Pharma Corp.
RAMM
CNSX
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.21% | 24.72% | 40.18% | -264.36% | 9.73% |
| Total Depreciation and Amortization | -2.36% | -0.74% | 38.90% | -36.48% | -17.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -252.44% | -87.16% | -65.25% | 1,107.13% | -338.53% |
| Change in Net Operating Assets | -208.61% | 2,411.11% | 75.48% | -118.92% | 144.86% |
| Cash from Operations | -10.19% | 13.67% | 12.40% | -105.65% | 45.70% |
| Capital Expenditure | -9,000.00% | 98.96% | 75.13% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 81.88% | -173.92% | 91.74% | -6.03% | 173.65% |
| Cash from Investing | 52.43% | -195.96% | -62.65% | 271.55% | 140.28% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.35% | -2.84% | -31.24% | 8.53% | 20.37% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 48.15% | -- | -- | 369.11% | 40.58% |
| Cash from Financing | 10.99% | -30.94% | -583.61% | 95.47% | -129.25% |
| Foreign Exchange rate Adjustments | -61.90% | 163.00% | -146.51% | 390.54% | -57.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.07% | 6.78% | 0.48% | -48.96% | 40.51% |
